Home
Services
Our Team
Hot Topics/News
Philosophy
Testimonials
Contact Us
Site Map
|
Eileen
Gorman, PhD, Principal
DNA Bridges®, Inc.
5 Bisbee Court, Suite 109-225
Santa Fe, NM 87508-1419
TEL 505-473-2703
FAX 505-474-9032
eileen@dnabridges.com
RECENT PUBLICATION
Building a diagnostics market: One molecule at a time
Dr. Eileen
Gorman is a recognized expert in technology development from inception
to commercialization. She has held leadership positions at the
business/technical interface, in research and development, and
technical marketing organization in medical products.
Dr. Gorman has served as technical consultant to the legal
department for management of intellectual property assets,
developed and implemented business strategies. She also provided
program evaluation, benchmarking, oversight and management of
product development collaborations with academic and
industrial partners. Under her lead, 5 products have been
commercialized. She possesses unique expertise and familiarity
with both the business and the technical side of business
development in industrial and academic settings.
For over 15 years, she was a member of the former DuPont
Diagnostics, now Siemens. She holds a
Ph.D. in chemistry with a specialization in biochemistry, and
was a Staff Fellow at NIH. She has authored over 50
papers, chapters, abstracts, corporate reports, and patents.
EXAMPLES OF TECHNICAL
BACKGROUND
Diagnostics Project Leadership
System
Integration
RECENT PUBLICATIONS
|
BIO 2005, June 2005, Philadelphia, PA |
The Dance at Closing—A
Mock Negotiation, Organizer and Moderator of panel
including angel investors, corporate founder, VCs
and technology transfer office members.
|
|
BIO 2005, June 2005, Philadelphia, PA
BIO 2005, June 2005, Philadelphia, PA |
Creative Funding Options—Think Outside the Box.
Organizer and Moderator of panel including corporate
CEO, VCs and consultants.
Chief Scientific Officer (CSO) Boot Camp speaker,
session addressing Capitalization of the Venture.
Session organized by Steven Sammut, Burrill and
Company.
|
|
February 2005, Texas AACC Section Annual Meeting |
Interrelationship of Drug Discovery, Development and
New Clinical Markers. Invited speaker for Symposium. |
SELECTED PUBLICATIONS
Gorman,
EG, Diagnostic (in vitro) Products - The New Futures of Diagnostic Testing,
Biomedical Medical and Healthcare Market Place Guide, ed. Dorland’s Biomedical: 2002-2003, vol. 1; pg.1512-1516.
Gorman, EG, Building a diagnostics market: One molecule at a time. IVD Technology, vol. 7 pg. 59-67.
Gorman, EG, The New Futures of Diagnostic Testing, Clinical Leadership & Management Review, vol. 14:1, p. 26-29, 2000.
Newman, DJ, Y. Olabiran, W.D. Bedzyk, S. Chance, Gorman,
EG and C.P. Price, Impact of Antibody Specificity and Calibration Material on the Measure
of Agreement between Methods for Cardiac Troponin I, Clinical Chemistry, p. 822-828, 1999.
Price,
C.P., J.
Calvin, S. A. Walker, A. K. Trull, D. J. Newman, and Gorman,
EG. A Rapid and
Sensitive Automated Light Scattering Immunoassay for Serum
C-reactive protein and the Definition
of a Reference Range in Healthy Blood Donors,
Clin Chem Lab Med, p. 107-113, 1999.
Gorman,
EG, Diagnostic (in vitro) Products - The New Futures of Diagnostic Testing,
Biomedical Medical and Healthcare Market Place Guide, vol. 1
, p.1545-1547, 1998.
Obzansky,
D.M., Gorman, EG, S.P. Kramer, I.S. Masulli, E.A. Nuzzai,
and W.F. Skogen, Analytical
and Clinical Performance of a Rapid Screening Method for
Cannabinoids on the Dimension®
Clinical Chemistry System,
Journal of Automatic Chemistry, 19/5, 169-173, 1997.
Gorman,
EG, R. Arentzen, W. Bedzyk, and LA. Cassidy, An Overview of Immunoassay Automation, 2nd Edition, in Principles
and Practice of Immunoassay, C.P. Price and D.J. Newman,
Eds. Macmillan, 1997.
PATENTS
| PATENT |
ISSUED |
TITLE |
| US4703018 |
10/27/87 |
High
Refractive Index Haloalkyl-Functional Shell-Core Polymers
and Their Use in Light Scattering Immunoassays |
|
